Radiopharmaceuticals

Ended Awarded

Contract number
HT009026FJ076
Awardee
Awarding agency
Obligated
$19,487

Award facts

Contract value 100% obligated
$19,486.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Princeton, NJ, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Sun Pharmaceutical Industries, Inc., on June 3, 2026, for radiopharmaceuticals with a ceiling value of $19,486.80. The call is firm fixed price and runs through September 30, 2026. Work is performed in Princeton, New Jersey. No set-aside was used. Sun Pharmaceutical is a for-profit manufacturer of pharmaceutical and radiopharmaceutical products supplying nuclear medicine imaging products and radiopharmaceuticals to federal healthcare agencies under full-and-open competitive procurements.

Quick answers

Who was awarded contract HT009026FJ076?

HT009026FJ076 was awarded to Sun Pharmaceutical Industries, Inc. by Defense Health Agency (Department of Defense) on June 3, 2026.

How much is contract HT009026FJ076 worth?

The government has obligated $19,487 on HT009026FJ076.

Is contract HT009026FJ076 an order under another contract?

Yes. HT009026FJ076 is a BPA call under HT001425A0012, a blanket purchase agreement.

Was contract HT009026FJ076 competed?

The extent of competition for HT009026FJ076 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award